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Background: Respiratory syncytial virus (RSV) is one of the most frequently observed pathogens during infancy
and childhood. However, the corresponding pathogenesis has not been determined to date. We previously
demonstrated that IFN-γ plays an important role in RSV pathogenesis, and SARM-TRIF-signaling pathway could
regulate the production of IFN-γ. This study is to investigate whether T cells or innate immune cells are the
predominant producers of IFN-γ, and further to explore other culprits in addition to IFN-γ in the condition of
RSV infection.
Methods: Normal BALB/c mice and nude mice deficient in T cells were infected intranasally with RSV. Leukocytes
in bronchoalveolar lavage fluid were counted, lung histopathology was examined, and airway hyperresponsiveness
(AHR) was measured by whole-body plethysmography. IFN-γ and MMP-12 were detected by ELISA. MMP408, a
selective MMP-12 inhibitor, was given intragastrically. Resveratrol, IFN-γ neutralizing antibody and recombinant
murine IFN-γ were administered intraperitoneally. SARM and TRIF protein were semi-quantified by Western blot.
siRNA was used to knock-down SARM expression.
Results: RSV induced significant airway inflammation and AHR in both mice; IFN-γ was significantly increased in
BALB/c mice but not in nude mice. MMP-12 was dramatically increased in both mice but earlier in nude mice.
When MMP-12 was inhibited by MMP408, RSV-induced respiratory symptoms were alleviated. SARM was significantly
suppressed while TRIF was significantly enhanced in both mice strains. Following resveratrol administration in nude
mice, 1) SARM inhibition was prevented, 2) TRIF and MMP-12 were correspondingly down-regulated and 3) airway
disorders were subsequently alleviated. Moreover, when SARM was efficiently knocked down using siRNA, TRIF and
MMP-12 were markedly enhanced, and the anti-RSV effects of resveratrol were remarkably abrogated. MMP-12 was
significantly increased in the IFN-γ neutralizing antibody-treated BALB/c mice but reduced in the recombinant
murine IFN-γ-treated nude mice.
Conclusions: MMP-12 can result in at least part of the airway inflammation and AHR independent of IFN-γ. And
SARM-TRIF- signaling pathway is involved in regulating the overproduction of MMP-12. To the best of our
knowledge, this study is the first that has examined the effects of SARM on MMP-12 and further highlights the
potential to target SARM-TRIF-MMP-12 cascades to treat RSV infection.
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Respiratory syncytial virus (RSV) bronchiolitis in infants
has long been a major public health and economic bur-
den worldwide, particularly in low- and middle-income
countries [1,2]. However, the development of efficient
vaccines or antiviral medicines has been impeded by the
as-yet contradictory pathogenic mechanisms [3].
We have demonstrated that IFN-γ is critical to the
pathogenesis of RSV infection. Reducing IFN-γ by anti-
IFN-γ antibody or resveratrol treatment significantly al-
leviated RSV-associated airway inflammation and airway
hyper-responsiveness (AHR) [4,5]. Both CD4+ Th1 cells
and CD8+ Tc1 cells contribute to the aberrant release of
IFN-γ triggered by RSV [6-8], while innate immune cells,
including NK cells and macrophages, among other cell
types, are also essential sources [9,10]. However, which
cell type is the primary producer of IFN-γ remains to be
determined. Nude mice are congenitally deficient in T
cells, but their innate immunity is normal or compensato-
rily enhanced [11]. Thus, we used this mouse model to in-
vestigate whether T cells or innate immune cells are the
predominant producers of IFN-γ. RSV caused significant
airway inflammation and AHR in nude mice, but unex-
pectedly, IFN-γ showed no perceivable changes through-
out the disease in nude mice, which indicated that other
non-T cells and non-IFN-γ proteins are involved.
In the absence of T cells, abundant macrophages were
recruited into the airway of RSV-infected nude mice. It
has been reported that macrophages can secrete MMP-
12 in response to viral challenge [12]. MMP-12, also
known as macrophage elastase, is a member of the matrix
metalloproteinases (MMPs) family. The role of MMP-12
in asthma and COPD has been well-recognized [13,14].
Moreover, in preparing this manuscript, Foronjy and col-
leagues recently demonstrated that excessive lung prote-
ase (including MMP-12) responses were induced by RSV,
and airway disorders could be alleviated by protease inhib-
itors [15]. When viewed in combination, it is reasonable
to propose that MMP-12 might account for RSV-induced
dysfunctions independent of T cells and IFN-γ.
Toll-like receptors (TLRs) and their down-stream
adapter proteins are intimately associated with RSV in-
fection. We demonstrated that sterile-α- and armadillo
motif-containing protein (SARM), one of the adapter
proteins, was suppressed by RSV [4]. SARM is a negative
regulator of Toll/IL-1R domain-containing adapter indu-
cing IFN-β (TRIF)-signaling cascades [16]. SARM sup-
pression has consequently resulted in the over-expression
of TRIF and IFN-γ and consequently resulted in RSV
disease in BALB/c mice. Furthermore, resveratrol, a
well-recognized antioxidant, could redress SARM-TRIF
imbalance by up-regulating SARM, thereby reducing
TRIF and IFN-γ, ultimately alleviating airway inflamma-
tion and AHR [4]. TLR signaling pathways also mediatedthe over-production of MMPs [17-19]. However, the role
of SARM-TRIF disturbance in the exacerbation of MMP-
12 has yet to be examined.
In the present study, we hypothesized that following
RSV challenge, MMP-12 can be mediated by SARM-TRIF-
signaling pathways similar to IFN-γ, and can result in
airway inflammation and AHR independent of IFN-γ and
T cells. Such studies will enhance our understanding of
SARM-TRIF-signaling cascades and may help to identify
new efficient strategies for the control of RSV infection.
Methods
Mice
In this study, six- to eight-week-old female BALB/c and
nude mice (on a BALB/c background), free of specific
pathogens, were purchased from the Animal Laboratory
of Chongqing Medical University. The mice were bred
under accredited specific pathogen-free conditions in
separate filter-top cages according to the experimental
design and were acclimated for at least one week prior
to treatment. All experiments involving animals were in
accordance with the Guide for the Care and Use of
Laboratory Animals and approved by the Institutional
Animal Care and Committee (IACUC), which is accre-
dited by the Association for Assessment and Accreditation
of Laboratory Animal Care International, China and Ex-
perimental Animal Committee of the Chongqing Medical
University (license numbers: SCXK(Yu) 2012–0001 and
SYXK(Yu) 2012–0001.
RSV preparation and mice treatment
We utilized the A2 strain of human RSV (American Type
Culture Collection). To inoculate RSV, the mice were held
upright after sedation and inoculated intranasally with
1.5 × 107 PFU RSV in a 100-μl volume or sham-infected
with 100-μl cell culture supernatant (mock group). To as-
sess the effect of MMP-12 on the airway inflammation
and AHR, both BALB/c mice and nude mice were treated
with MMP408, a potent and specific MMP-12 inhibitor,
(CALBIOCHEM, EMD Chemicals, Inc. San Diego, CA
92121) at 5 mg/kg or PBS intragastrically twice a day from
day 0 to day 8 post infection. Disease parameters were
assessed on day 9. To assess the role of SARM-TRIF sig-
naling pathway on MMP-12 regulation, nude mice were
injected intraperitoneally with either resveratrol (Sigma-
Aldrich Corp., St. Louis, MO) at 30 mg/kg/day [4] or PBS
on day 0 (1 h post-RSV infection) and on days 1 to 4
consecutively. To assess the effects of IFN-γ on MMP-
12 production, BALB/c mice were treated with IFN-γ
neutralizing antibody (R4-6A2; BD PharMingen, San
Diego, CA) and and nude mice were treated with re-
combinant murine IFN-γ (PeproTech, inc. Rocky Hill,
NJ). IFN-γ neutralizing antibody (100 μg) and recombin-
ant murine IFN-γ (10 μg) were injected intraperitoneally
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post infection. Disease parameters were assessed on day
5. The corresponding isotype control antibodies were
given similarly.
Analysis of infiltrated inflammatory cells in BALF
Bronchoalveolar lavage fluid (BALF) was collected for
cytokine concentration measurement and inflammatory
cell evaluation as previously described [5]. Briefly, we
lavaged the bronchial alveolar system of the mice with
0.5 ml ice-cold sterile PBS gently six times. The resultant
BALF was centrifuged at 2500 rpm for 5 min at 4°C. Cell-
free supernatant was aliquoted and stored at −80°C for
subsequent cytokine detection. The remaining sediments
were resuspended in 1 ml PBS. The total number of cells
was quantified using microscopy. Cytospin slides were
fixed and stained with DiffQuik (Baxter Healthcare Corp,
Deerfield, Miami, FL) for leukocyte differential analysis.
The number of neutrophils, macrophages, and lympho-
cytes in at least 200 cells per slide was quantified in a blind
manner using a hemocytometer at × 1000 magnification.
Morphological examinations
Mice were euthanized by cervical dislocation, and their
left lung lobes were removed and fixed in 10% buffered
formalin for 24 h. The lungs were then embedded in par-
affin, cut into 5-mm-thick sections and stained with HE
(hematoxylin and eosin) to evaluate RSV-associated pul-
monary histopathology. To semi-quantitatively estimate
lung lesions, a histopathological score (HPS) was per-
formed as previously described [20]. The criteria assigned
were 0 for no inflammation and 1, 2, and 3 for mild, mod-
erate, and severe inflammation, respectively.
RSV-induced AHR measurement
We used whole-body plethysmography (Emca instrument;
Allmedicus, France) to assess airway hyperresponsiveness
(AHR) at days 1, 3, 5 and 7 post-RSV inoculation. Briefly,
conscious and spontaneously breathing mice were ex-
posed to aerosolized phosphate-buffered saline (PBS) solu-
tion, followed by increasing concentrations of aerosolized
methacholine solution (3.125, 6.25, 12.5, 25, 50 mg/ml;
Sigma, USA) in PBS, for 3 min exposures. After each
nebulization, there was a 2-min internal quiescent, and
the enhanced pause (Penh) was calculated over the sub-
sequent 5 min. Penh is a dimensionless parameter that
represents pulmonary airflow resistance (Penh = PEP/
PIP× pause).
Determination of cytokines
The levels of IFN-γ and MMP-12 in BALF were measured
using an enzyme-linked immunosorbent assay (ELISA)
with commercial kits (Sizhengbai Beijing China) accordingto the manufacturer’s instructions. Duplicate wells were
run, and the mean values were reported.
Flow cytometry
Single-cell suspensions of lung were prepared and cells
were incubated with PMA (50 ng/ml; Sigma), ionomycin
(1000 ng/ml; Sigma) and GolgiPlug-containing brefeldin
A (BD Biosciences) in 1 ml complete RPMI (RPMI 1640
medium supplemented with 10% fetal bovine serum,
2 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml
streptomycin). After 4–6 h incubation, the cells were
harvested and blocked with antibody to mouse CD16/
CD32 (Fc Block, BD). Samples were immunostained with
antibody to mouse CD3, CD4, CD8 or isotype control
conjugated with PerCP-cy5.5, FITC or PeCy7 for 30 mi-
nutes on ice and then fixed with 1% Formaldehyde in
FACS Staining Buffer. The indicated antibodies were
obtained from eBioscience (San Diego, CA). For intra-
cellular IFN-γ detection, cells were fixed and perme-
abilized with CytoFix/CytoPerm solution (554722; BD)
and Perm/Wash buffer (554723; BD) and then stained
with APC-conjugated anti-IFN-γ mAb (BD Biosciences).
Stained samples were measured on a flow cytometer,
FACSCalibur (BD Biosciences). The data were analyzed
using CellQuest software (BD Biosciences).
Western blotting analysis
The total protein of lung tissues were extracted using a
total protein extraction kit (KeyGEN, Nanjing, China).
Samples containing equal quantities of protein were
separated on an 8% SDS-PAGE (sodium dodecyl sulfate-
polyacrylamide gel electrophoresis) gel and then trans-
ferred onto polyvinylidene difluoride (PVDF) membranes
(Millipore, Billerica, MA). Membranes were probed with
primary antibodies against SARM (1:500; SANTA, USA),
TRIF (1:500; Abcam, Cambridge, MA) or β-actin (1:5,000;
4abio, Beijing, China). Alkaline phosphatase-conjugated
goat anti-rabbit secondary antibody (1:10,000; Multi-
Sciences, China) and goat anti-mouse antibody (1:10,000;
MultiSciences, China) were used to detect the presence of
the respective protein bands. Signals were quantified using
Quantity One software (Bio-Rad, Hercules, CA) and nor-
malized relative to β-actin.
In vivo siRNA transfection
GFP-tagged siRNAs of SARM were purchased from
Invitrogen (Shanghai, China) using the following se-
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GTCAGTCAGTGGCCAAAACGTCTCCACGCGCAGT
ACATTTc. We excluded the ectopic expression of SARM
siRNA 3–1 in other organs and minimized its off-targets
effects [4]. siRNA was dissolved in a solution of 5% glu-
cose and in vivo jetPEI (Polyplus Transfection, New York,
NY, USA) to an N/P ratio of 7 (number of nitrogen resi-
dues of jetPEI per RNA phosphate), and a total of 80 μL
of siRNA-jetPEI complex was administered intranasally to
nude mice on the fourth day post-infection. Disease pa-
rameters were assessed, and the samples were harvested
at day 5 post-infection.Statistical analysis
All statistical tests were performed using Prism GraphPad
Software (La Jolla, CA), and the results are expressed as
the mean ± SEM. Two-way ANOVA with Bonferroni
post-tests were used to compare the differences among
multiple groups to AHR. Analysis of variance (ANOVA)
was used to determine the differences between all
groups to other indices. Data lacking normal distribu-
tion were evaluated using the nonparametric Kruskal-
Wallis test, followed by Dunn’s multiple comparison.
Differences were considered to be significant for p-values
less than 0.05.Figure 1 RSV infection results in an increase in BALF cellularity. Mice
sacrificed at days 1, 3, 5, 7 and 9 post-infection. Total cells (A), macrophage
increased following RSV challenge in both BALB/c mice and nude mice. Gr
two independent experiments performed on 10 animals per group. *, p < 0
mice groups are connected by a line.Results
RSV induces significant airway inflammation and AHR in
BALB/c mice and nude mice
In the absence of T cells, we found that RSV triggered sig-
nificant airway inflammation and AHR in nude mice. As
shown in Figure 1, abundant leukocytes (Figure 1A), in-
cluding macrophages (Figure 1B), lymphocytes (Figure 1C)
and neutrophils (Figure 1D) infiltrated into the bron-
choalveolar lavage fluid (BALF) at days 1, 3, 5, 7 and 9
post-infection. Importantly, there were more macro-
phages and less lymphocytes in nude mice compared to
BALB/c mice.
Lung tissue damage is another parameter of RSV-
associated dysfunction. As shown in Figure 2 A and G, no
pulmonary hyper-cellularity or other pathological charac-
teristics were observed in the mock-infected mice. How-
ever, at days 1 (Figure 2B and H), 3 (Figure 2C and I), 5
(Figure 2D and J), 7 (Figure 2E and K), and 9 (Figure 2F
and L) post-infection, a mass of inflammatory cells accu-
mulated around the bronchiole, vascular, and alveolar
compartments, with goblet cell hyperplasia, mucus hyper-
secretion, and partial destruction of normal tissue struc-
tures in both BALB/c mice and nude mice. Corresponding
to the morphological changes, the histological scores of
lung tissues (Figure 2M) were significantly enhanced in
RSV-challenged BALB/c mice and nude mice.were infected with 1.5 × 107 PFU of RSV and a group of animals were
s (B), lymphocytes (C) and neutrophils (D) were all significantly
aphs are represented as the mean ± s.e.m. Data are representative of
.05, **, p < 0.01, ***, p < 0.001 shown comparing the corresponding
Figure 2 RSV infection results in significant lung histopathological lesions. Lungs were harvested at days 1, 3, 5, 7 and 9 post-RSV infection,
stained with hematoxylin-and-eosin (HE), and scored for levels of inflammation as described in the Materials and Methods section. Representative
HE staining of mouse lung tissue sections (original Magnification × 100) were shown. A: mock-infected BALB/c mice; B-F: RSV-infected BALB/c
mice at days 1, 3, 5, 7 and 9 respectively. G: mock-infected nude mice; H-L: RSV-infected nude mice at days 1, 3, 5, 7 and 9 respectively. RSV
induced a mass of inflammatory cells accumulation around the bronchiole, vascular and alveolar compartments, with goblet cell hyperplasia,
mucus hypersecretion as well as partial destruction of regular tissue structures. M: Histological scores were remarkably elevated in the RSV-infected
mice compared with the mock group. Graphs are representative of two independent experiments performed on 10 animals per group. *, p < 0.05,
**, p < 0.01, ***, p < 0.001 shown comparing the corresponding mice groups are connected by a line.
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that Penh values (enhanced pauses) were similarly ele-
vated in BALB/c mice and nude mice at days 1, 3, 5, 7
and 9 post-infection (Figure 3A-E).
T cells are the primary cellular sources of IFN-γ induced
by RSV
We and others have demonstrated the critical role of
IFN-γ in the pathogenesis of RSV infection. Using flow
cytometry, we confirmed that CD3+ T cells were nearly
undetectable in nude mice (Figure 4A). Unexpectedly,
IFN-γ showed no perceivable changes in nude mice
throughout the assessed time points, but it was dramat-
ically elevated in BALB/c mice at day 5 (p < 0.01) and
day 7 (p < 0.05) post-infection (Figure 4B). In addition,
IFN-γ was not exacerbated by RSV in NOD/SCID mice,
which are deficient in both T cells and B cells (Additional
file 1). Thus, IFN-γ could not be induced by RSV in the
absence of T cells. We further demonstrated that CD3+
CD4+IFN-γ+ Th1 and CD3+CD8+IFN-γ+ Tc1 cells were
both significantly increased at day 5 when IFN-γ reached
its peak level (Figure 4C). Taken together, these results in-
dicated that T cells are the primary cellular sources ofIFN-γ in the case of RSV infection; nevertheless, RSV can
result in significant airway diseases independent of T cells
and IFN-γ.MMP-12 contributes to RSV-induced resriratory symptoms
In search of the culprits that are responsible for airway
disorders in the absence of T cells and IFN-γ, we found
that MMP-12 levels were substantially increased in nude
mice at days 3, 5, 7 and 9 post-infection. MMP-12 was not
exacerbated in BALB/c mice on days 1, 3 and 5, whereas
on day 7, MMP-12 tended to be elevated (p = 0.0672 vs.
mock group), and on day 9, MMP-12 was significantly
increased (Figure 5A). To further assess the effects of
MMP-12 on airway inflammation and AHR caused by
RSV, MMP408, a specific inhibitor of MMP-12 was ad-
ministrated to mice. As shown in Figure 5B, MMP-12
was significantly blocked by MMP408. Moreover, airway
inflammation (Figure 5C, D) and AHR (Figure 5E, F) of
BALB/c mice and nude mice were both dramatically re-
duced in the MMP408-treated mice groups. Thus, MMP-
12 can mediate at least part of the RSV-associated airway
inflammation and AHR.
Figure 3 RSV infection results in enhanced AHR. Airway hyperresponsiveness to increasing doses of methacholine was assessed using
plethysmography at days 1 (A), 3 (B), 5 (C), 7 (D) and 9 (E) post-RSV infection. Penh values were significantly increased at all indicated time points
following RSV challenge in both BALB/c mice and nude mice. Graphs are represented as the mean ± s.e.m. Data were representative of two
independent experiments performed on 10 animals per group. *, p < 0.05, **, p < 0.01, ***, p < 0.001 for RSV-infected versus mock-treated BALB/c
mice; ^, p < 0.05, ^^, p < 0.01, ^^^, p < 0.001 for RSV-infected versus mock-treated nude mice.
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In RSV-infected BALB/c mice, resveratrol treatment could
significantly 1) suppress TRIF but prevent the RSV-
mediated reduction of SARM expression; 2) decrease
IFN-γ levels; and subsequently 3) reduce airway inflamma-
tory cells and AHR (Additional file 2). Similar results have
been published [4]. To examine the role of SARM-TRIF in
MMP-12 modulation further, resveratrol and SARM
siRNA were used to disrupt SARM-TRIF expression levels
in nude mice. Nude mice were divided into five groups:
control: mock-infected and PBS treated; RSV: RSV-
infected and PBS treated; RSV + RES: RSV-infected andFigure 4 IFN-γ induced by RSV is predominantly produced by T cells.
found that IFN-γ was significantly increased at days 5 and 7 post-RSV infec
further found that both CD3+CD4+IFN-γ+ Th1 cells and CD3+CD8+IFN-γ+ Tc
in BALB/c mice (C). Data are representative of two independent experimen
p < 0.001 shown comparing the corresponding mice groups are connectedresveratrol treated; RSV + RES + 3-1: RSV-infected, res-
veratrol treated and SARM siRNA 3–1 administrated;
RSV + RES + Negative: RSV-infected, resveratrol treated
and negative siRNA vector administrated. Animals were
killed at day 5 post-infection and all measurements were
performed on this day.
As shown in Figure 6A , airway infiltration of total in-
flammatory cells (p < 0.01), macrophages (p < 0.01) and
lymphocytes (p < 0.01) was dramatically decreased in the
RSV + RES group compared to the RSV group; and total
inflammatory cells (p < 0.001), macrophages (p < 0.01)
and lymphocytes (p < 0.01) were dramatically increased
in the RSV + RES + 3-1 group compared to the RSV +We confirmed that nude mice were deficient in CD3+ T cells (A) and
tion in BALB/c mice, but was nearly negligible in nude mice (B). We
1 cells were remarkably elevated at day 5 when IFN-γ levels peaked
ts performed on 6 animals per group. *, p < 0.05, **, p < 0.01, ***,
by a line.
Figure 5 MMP-12 contributes to RSV-induced resriratory symptoms. Mice were killed at days 1, 3, 5, 7 and 9 post-infection, and MMP-12
was detected using ELISA. A: MMP-12 levels in BALF. B: MMP-12 levels following MMP408, a specific inhibitor of MMP-12,administration. C:
Inflammatory cells in BALB/c mice. D: Inflammatory cells in nude mice. E: AHR in BALB/c mice. F: AHR in nude mice. mock: mock-infected mice
group; control: mock-infected and PBS treated mice group; RSV: RSV-infected and PBS treated mice group; RSV + MMP408: RSV-infected and
MMP408 treated mice group, Disease parameters were assessed on day 9 and data are representative of two independent experiments
performed on 6–10 animals per group. *, p < 0.05, **, p < 0.01, ***, p < 0.001 shown comparing the control mice groups to other groups.
^, p < 0.05, ^^, p < 0.01, ^^^, p < 0.001 for RSV + PBS groups versus the RSV + MMP408 groups.
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the RSV + RES group was almost equal to those of the
control group, and AHR was significantly increased in the
RSV + RES + 3-1 group compared to the RSV + RES +
Negative group.
As shown in Figure 6C and D, SARM was significantly
decreased (p < 0.001) while TRIF (P < 0.01) was signifi-
cantly increased in the RSV group compared to the con-
trol group; following resveratrol administration, SARM
inhibition was substantially prevented (p < 0.01), while
TRIF (p < 0.05) was substantially down-regulated in the
RSV + RES group compared to the RSV group. Moreover,
when SARM expression was effectively knocked down by
siRNA 3–1 (p < 0.01), the levels of TRIF (p < 0.05) was re-
markably elevated in the RSV + RES + 3-1 group in con-
trast to the RSV +RES+ Negative group.
As shown in Figure 6E, MMP-12 was significantly
decreased in the RSV + RES group compared to the RSV
group (p < 0.01). Moreover, MMP-12 was significantly
increased in the RSV + RES + 3-1 group compared to theRSV + RES+ Negative group. Taken together, these data
indicated that SARM-TRIF signaling pathway is involved
in regulating MMP-12 expression.
IFN-γ suppresses MMP-12
As mentioned above, MMP-12 was not significantly in-
creased in RSV-infected BALB/c mice on day 5 when
IFN-γ reached the peak, but tended to be increased on
day 7 when IFN-γ began to decrease and significantly
increased on day 9 when IFN-γ completely returned to
baseline levels. Moreover, in the absence of IFN-γ in
nude mice, MMP-12 was significantly increased on days
3, 5, 7 and 9. It was plausible to propose that IFN-γ
might be able to suppress MMP-12 in the condition of
RSV challenge. To confirm this, we treated BALB/c mice
and nude mice with IFN-γ neutralizing antibody and re-
combinant murine IFN-γ respectively. IFN-γ levels were
significantly decreased by neutralizing antibody treatment
in BALB/c mice (Figure 7A), but were significantly
increased by recombinant murine IFN-γ treatment in
Figure 6 SARM-TRIF signaling pathway is involved in regulating MMP-12 expression. Nude mice were inoculated with RSV or mock
infected with the culture supernatant. Resveratrol or PBS was injected intraperitoneally for 5 days consecutively. SARM siRNA 3–1 and the
negative siRNA vector were transfected intranasally. The disease parameters were assessed at day 5 post-RSV infection. Nude mice were divided
into five groups: control: mock-infected and PBS treated mice group; RSV: RSV-infected and PBS treated mice group; RSV + RES: RSV-infected
and resveratrol treated mice group; RSV + RES + 3-1: RSV-infected, resveratrol treated and SARM siRNA 3–1 transfected mice group; RSV + RES +
Negative: RSV-infected, resveratrol treated and negative siRNA vector administrated mice group. A: Inflammatory cells infiltrating into BALF.
B: AHR in response to increasing doses of methacholine. C: Western blotting analysis of the expression of SARM and TRIF in the lung tissues. D:
Semi-quantified expression of SARM and TRIF normalized to β-actin. E: MMP-12 protein levels in BALF. Data are representative of two independent
experiments performed on 12 animals per group. In graph B, ***, p < 0.001 shown comparing the RSV group to the RSV + RES group; ^^^,
p < 0.001 shown comparing the RSV + RES + 3-1 group to the RSV + RES + Negative group. In the other graphs, *, p < 0.05, **, p < 0.01, ***,
p < 0.001 shown comparing the corresponding mice groups are connected by a line.
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Figure 7 IFN-γ suppresses MMP-12. To assess the effects of IFN-γ on MMP-12 production in the condition of RSV challenge, BALB/c mice were
treated with IFN-γ neutralizing antibody and nude mice were treated recombinant murine IFN-γ on days 0, 1, and 3 respectively. Samples were
collected on day 5. A: IFN-γ levels in BALB/c mice. B: IFN-γ levels in nude mice. C: MMP-12 levels in BALB/c mice. D: MMP-12 levels in nude mice.
control: mock-infected and PBS treated mice group; RSV + anti-IFN-γ: RSV-infected and IFN-γ neutralizing antibody treated BALB/c mice group;
RSV + r-IFN-γ: RSV-infected and recombinant murine IFN-γ treated nude mice group, RSV: RSV-infected and isotype control antibodies treated
BALB/c mice or nude mice groups. Data are representative of two independent experiments performed on 6–10 animals per group. *, p < 0.05,
**, p < 0.01, ***, p < 0.001 shown comparing the the corresponding mice groups are connected by a line.
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cantly increased in BALB/c mice treated with IFN-γ
neutralizing antibody (Figure 7C), but was significantly
decreased in nude mice treated with recombinant mur-
ine IFN-γ (Figure 7D).
Discussion
In this study, we demonstrated that (1) T cells are the
predominant cellular sources of IFN-γ induced by RSV;
(2) MMP-12 accounts for at least part of the airway
inflammation and AHR caused by RSV independent of
IFN-γ; (3) SARM-TRIF signaling pathway is involved in
regulating MMP-12 expression; and (4) IFN-γ can suppress
MMP-12 expression in the condition of RSV challenge.
IFN-γ was significantly elevated in BALB/c mice, but
not in nude mice or NOD/SCID mice, which are both
deficient in T cells. Both CD3+CD4+IFN-γ+ Th1 cells and
CD3+CD8+IFN-γ+ Tc1 cells were remarkably increased in
BALB/c mice. These results strongly suggested that T cells
are the primary producers of IFN-γ triggered by RSV. Our
findings were consistent with recent evidence that in the
PVM mouse model for human RSV, IFN-γ was undetect-
able until day 5 post-infection, at which time, CD8+ T cells
infiltrated into the lung [7]. NK cells and macrophages
and other cell types have been previously reported to be
potential producers of IFN-γ [9,10]. Nevertheless, these
conclusions were mainly drawn from mouse models withcompetent T cell responses, thus it cannot exclude the
possibility that innate immune cells act as adjuvants of
overt IFN-γ secretion by enhancing T cells activity. In-
deed, activated NK cells are able to prime DCs to pro-
duce IL-12 and to induce highly protective CD8+ T cell
memory responses [21]. However, Zhou et al. [22] have
reported that nude mice have reduced IFN-γ levels on
day 3 post RSV infection in contrast to BALB/c mice.
The authors used 8–12 week old mice and they inocu-
lated mice intranasally with 105 PFU RSV in a volume
of 50 μl. These differences might be responsible for part
of the contradictions. In addition, the authors did not
clarify the background of their nude mice model. Thus,
the biological changes observed might also be back-
ground dependent.
In contrast to IFN-γ, MMP-12 was remarkably in-
duced by RSV in both mice strains but earlier in nude
mice. And when MMP-12 was suppressed by MMP408,
airway inflammation and AHR were dramatically allevi-
ated. Several previous studies have shown that RSV trig-
gers dramatic up-regulation of lung proteases which can
delay viral clearance and facilitate airway inflammation
and AHR [12,15]. Foronjy et al. [15] have recently ob-
served that MMP-12 was significantly increased on days
1, 3, 5, 7 and 9 in Friend leukemia virus B sensitive
strain mice. Moreover, Marchant et al. [23] further re-
ported that RSV challenge resulted in greater viral loads
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terparts. However, no researches have discussed the spe-
cific effects of MMP-12 on RSV pathogenesis to date. Our
results clearly indicate that MMP-12 can lead to airway in-
flammation and AHR caused by RSV. Thus, therapies tar-
geting MMP-12 may be promising anti-RSV options.
Cells of the monocyte-macrophage lineage are the lar-
gest source of MMP-12 in vivo and MMP-12 is critical
for macrophages migration [24,25]. In nude mice, mac-
rophages and MMP-12 were both significantly induced
by RSV, and were both significantly reduced by resvera-
trol and MMP408 treatment. Our in vitro study has fur-
ther shown that MMP-12 was dramatically increased in
the RSV-challenged RAW 264.7 cells (Additional file 3).
Thus, macrophages might contribute to the increased
MMP-12 levels in our nude mice models, however,
without specific cellular depletion, we can not identify
the relationship of macrophages and MMP-12 in the
present study.
Interestingly, although with a smaller magnitude, mac-
rophages were also strongly induced in BALB/c mice on
days 3, 5 and 7 following RSV challenge. Nevertheless,
MMP-12 was not increased simultaneously. There are
two possibilities for these divergences. First, macro-
phages might be phenotypically or functionally different
in RSV-infected nude mice. Indeed, it has been demon-
strated that in the absence of efficient lymphocyte and
IFN-γ responses, macrophages failed to express a classic-
ally activated phenotype in response to RSV [26-28]. The
second possibility is that MMP-12 was suppressed by
IFN-γ. In our BALB/c mice models, MMP-12 tended to
be increased on day 7 when IFN-γ began to decrease and
was significantly increased on day 9 when IFN-γ com-
pletely returned to baseline levels. Moreover, after IFN-γ
was neutralized in BALB/c mice, MMP-12 was signifi-
cantly increased. And after IFN-γ was elevated by recom-
binant murine IFN-γ treatment in nude mice, MMP-12
was significantly decreased. It has been reported that IFN-
γ can protect mice against aneurysm formation and block-
ade of IFN-γ signaling pathways resulting in abdominal
aortic aneurysms primarily due to increased MMP-12
expression [29]. In addition, in vitro studies have also
demonstrated that IFN-γ can inhibit MMP-9 in human
monocytes and macrophages [30] and in murine peri-
toneal macrophages [31], as well as MMP-12 in murine
macrophages [32].
The critical role of TLRs-SARM-TRIF-IFN-γ signaling
pathways in the pathogenesis of RSV disease has been
well-documented [4,5]. Our results further demon-
strated that SARM-TRIF signaling pathway is involved
in regulating MMP-12 expression. RSV infection signifi-
cantly down-regulated SARM, and once SARM was re-
stored by resveratrol treatment, the levels of MMP-12
were substantially reduced, which was accompanied byalleviated airway inflammation and AHR. In contrast,
SARM knockdown almost completely reversed the anti-
RSV effects of resveratrol. Foronjy et al. [15] indicated
that TLR3-TRIF only partially regulated the protease re-
sponse and RIG-I-MAVS exerted a far more substantial
effect on airway proteases responses following RSV in-
fection in Friend leukemia virus B sensitive strain mice.
However, in our mice models, MAVS was significantly
decreased (Additional file 4). These contradictions might
be attributed to the mice strain differences. TLR3-TRIF
has been recognized as important players in enhancing
MMPs responses [19,33]. However, to the best of our
knowledge, this is the first study to examine the effects of
SARM on MMP-12.
Conclusions
In summary, MMP-12 can result in at least part of the
RSV-induced airway inflammation and AHR independent
of IFN-γ and T cells. SARM-TRIF signaling pathways are
critical for regulating RSV-induced airway inflammation
and AHR, either by mediating overzealous T cells-IFN-γ
responses or by mediating exacerbated macrophages-
MMP-12 responses. These findings help to elucidate the
complicated network of TLRs and lung proteases trig-
gered by RSV and further highlight the potential to tar-
get SARM-TRIF- MMP-12 signaling cascades in the
treatment of RSV infection.
Additional files
Additional file 1: IFN-γ was not induced by RSV infection in NOD/
SCID mice. Six to eight weeks old NOD/SCID mice which are deficient in
both T and B cells were inoculated intranasally with 1.5 × 107 PFU RSV in
a 100 μl volume or sham-infected with 100-μl cell culture supernatant
(mock group). On day 5 post-infection, mice were killed and IFN-γ in
BALF was detected using ELISA. IFN-γ was not increased in NOD/SCID
mice on day 5. n = 4 in each group.
Additional file 2: Effects of resveratrol treatment on RSV infection
in BALB/c mice. BALB/c mice were treated with resveratrol or PBS as
described in the Materials and Methods section. Mice were divided into
three groups: control: mock-infected and PBS treated; RSV: RSV-infected
and PBS treated; RSV + RES: RSV-infected and resveratrol treated. Disease
parameters were detected on day 5 post infection. A: Western blotting
analysis of the expression of SARM and TRIF in the lung tissues. B:
Semi-quantified expression of SARM and TRIF normalized to β-actin. C:
IFN-γ levels in BALF. D: Inflammatory cells infiltrating into BALF. E: AHR
in response to increasing doses of methacholine. n = 4. *, p < 0.05, **,
p < 0.01, ***, p < 0.001 shown comparing the control mice groups to
other groups.^, p < 0.05, ^^, p < 0.01, ^^^, p < 0.001 for RSV groups
versus the RSV + RES groups.
Additional file 3: MMP-12 was significantly increased in RSV-
treated RAW264.7 cells. The murine macrophage cell line RAW264.7
was purchased from ATCC and was cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM: GIBCO) at 37°C under 5% CO2. After an
overnight culture, RAW264.7 cells in a 24-well plate was infected with
RSV at a multiplicity of infection (MOI) of 0.5, 1 and 2 for 2 hours (h).
To remove extracellular RSV, the cells were washed twice with 1 ml of
PBS. The infection was allowed to continue for 24 h, 48 h, or 72 h.
Supernatants were collected for MMP-12 detection at each time point.
MMP-12 was significantly increased by RSV in the RAW 264.7 cells.
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groups are connected by a line.
Additional file 4: MAVS was significantly suppressed by in RSV.
Lung tissues of both BALB/c mice and nude mice were harvested on day
7 post RSV infection. Total protein was extracted and western blot
analyses were performed as described in the Materials and Methods
section.The primary antibodies against MAVS (1:500; SANTA, USA), or
β-actin (1:5,000; 4abio, Beijing, China) and Alkaline phosphatase-
conjugated goat anti-rabbit secondary antibody (1:10,000; MultiSciences,
China) and goat anti-mouse secondary antibody (1:10,000; MultiSciences,
China) were used. MAVS was suppressed by RSV in both BALB/c mice
(A) and nude mice (B).
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